Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug

Cancer Chemother Pharmacol. 2009 Oct;64(5):863-6. doi: 10.1007/s00280-009-1086-6. Epub 2009 Jul 29.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Glioblastoma / drug therapy*
  • Humans
  • Methylation
  • Neoplasm Recurrence, Local / drug therapy
  • Nitrosourea Compounds / therapeutic use*
  • O(6)-Methylguanine-DNA Methyltransferase / genetics
  • Organophosphorus Compounds / therapeutic use*
  • Promoter Regions, Genetic / genetics
  • Randomized Controlled Trials as Topic

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • O(6)-Methylguanine-DNA Methyltransferase
  • fotemustine